Thursday, 6 November 2025
  
Login

Australia's most trusted
source of pharma news

Thursday, 06 November 2025
News

New era: J&J completes break up

Posted 24 August 2023 PM

Johnson & Johnson has finalised its separation from its healthcare business, with shareholders flocking to exchange their J&J shares for holdings in the new company, Kenvue.

The pharma giant ran an offer for its shareholders to swap each of their shares in J&J for 8.0324 shares of Kenvue common stock, with the offer being heavily over-subscribed. Only 23.86 per cent of J&J shares tended for exchange were accepted in the offer.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (4)

Sales & Customer Relations (17)

Clinical & Medical, R&D (7)

Regulatory, Pharmacovigilance & QA (3)

Other (13)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.